Juho Jalkanen
University of Turku(FI)Turku University Hospital(FI)Faron Pharmaceutical (Finland)(FI)
Publications by Year
Research Areas
Peripheral Artery Disease Management, Cardiac, Anesthesia and Surgical Outcomes, Atherosclerosis and Cardiovascular Diseases, Extracellular vesicles in disease, Aortic aneurysm repair treatments
Most-Cited Works
- → The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study(2013)146 cited
- → Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome(2020)134 cited
- → Aberrant Circulating Levels of Purinergic Signaling Markers Are Associated With Several Key Aspects of Peripheral Atherosclerosis and Thrombosis(2015)50 cited
- → Interferon beta-1a for COVID-19: critical importance of the administration route(2020)45 cited
- → Metastable Atrial State Underlies the Primary Genetic Substrate for MYL4 Mutation-Associated Atrial Fibrillation(2019)43 cited
- → Toe Pressure and Toe Brachial Index are Predictive of Cardiovascular Mortality, Overall Mortality, and Amputation Free Survival in Patients with Peripheral Artery Disease(2017)42 cited